SecBot SecBot
SECBOTREPLAY Home › Report › RCKT

RCKT · Rocket Pharmaceuticals, Inc

ROCKET PHARMACEUTICALS, INC. · EFFECT filed Mar 11, 2026 at 00:15 ET

At the news

NEUTRALIMPACT 4/10

EFFECT filed Mar 11, 2026 at 00:15 ET

Rocket Pharmaceuticals, Inc. has an effective shelf registration (Form S-3) as of March 10, 2026, allowing the company to issue unspecified securities from time to time. This creates a potential for future dilution, though no specific offering size or terms were disclosed.

  • Form S-3 shelf registration became effective on March 10, 2026.
  • The filing is a general offering statement, permitting the company to sell securities in one or more offerings without filing a new registration.
  • No specific offering size, pricing, or use of proceeds was disclosed in this filing.
  • The company may issue common stock, preferred stock, debt, or warrants under this shelf.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access